Garfield Alastair
Chief Scientific Officer
Officer
Latest Insider Transactions
5 transactions (past 365 days)
| 2026-07-02 | 2026-07-01 | RYTM Rhythm Pharmaceuticals, Inc. | CSO | Tax Payment | 2,150 | $110.41 | $237,382 |
| 2026-07-02 | 2026-07-01 | RYTM Rhythm Pharmaceuticals, Inc. | CSO | Exercise Conversion | 4,445 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | RYTM Rhythm Pharmaceuticals, Inc. | CSO | Award | 25,000 | $0.00 | $0 |
| 2026-02-03 | 2026-02-01 | RYTM Rhythm Pharmaceuticals, Inc. | CSO | Exercise Conversion | 6,663 | $0.00 | $0 |
| 2026-02-03 | 2026-02-01 | RYTM Rhythm Pharmaceuticals, Inc. | CSO | Tax Payment | 2,026 | $108.99 | -$220,814 |
RYTM
CSO
Tax Payment
$237.4K
2,150 shares @ $110.41
Filed 2026-07-02Trade 2026-07-01
Rhythm Pharmaceuticals, Inc.RYTM
CSO
Exercise Conversion
$0
4,445 shares @ $0.00
Filed 2026-07-02Trade 2026-07-01
Rhythm Pharmaceuticals, Inc.RYTM
CSO
Exercise Conversion
$0
6,663 shares @ $0.00
Filed 2026-02-03Trade 2026-02-01
Rhythm Pharmaceuticals, Inc.RYTM
CSO
Tax Payment
-$220.8K
2,026 shares @ $108.99
Filed 2026-02-03Trade 2026-02-01
Rhythm Pharmaceuticals, Inc.